nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—chronic kidney failure	0.0239	0.0239	CbGpPWpGaD
Tazarotene—CYP2C8—Diclofenac Metabolic Pathway—CYP2B6—chronic kidney failure	0.0228	0.0228	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—chronic kidney failure	0.0214	0.0214	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—chronic kidney failure	0.0206	0.0206	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.02	0.02	CbGpPWpGaD
Tazarotene—CYP2C8—Diclofenac Metabolic Pathway—CYP2C18—chronic kidney failure	0.0198	0.0198	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.0181	0.0181	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.018	0.018	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—chronic kidney failure	0.0174	0.0174	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—chronic kidney failure	0.0172	0.0172	CbGpPWpGaD
Tazarotene—CYP2C8—Diclofenac Metabolic Pathway—CYP2C19—chronic kidney failure	0.0164	0.0164	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.0163	0.0163	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—SREBF1—chronic kidney failure	0.016	0.016	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—chronic kidney failure	0.0156	0.0156	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—chronic kidney failure	0.0156	0.0156	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—chronic kidney failure	0.0149	0.0149	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—SREBF1—chronic kidney failure	0.0144	0.0144	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—chronic kidney failure	0.0139	0.0139	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—SREBF1—chronic kidney failure	0.0138	0.0138	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—SREBF1—chronic kidney failure	0.0138	0.0138	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—chronic kidney failure	0.0124	0.0124	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—chronic kidney failure	0.0119	0.0119	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—chronic kidney failure	0.0119	0.0119	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.0114	0.0114	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.0112	0.0112	CbGpPWpGaD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—SCARB1—chronic kidney failure	0.011	0.011	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.0102	0.0102	CbGpPWpGaD
Tazarotene—CYP2C8—CYP2E1 reactions—CYP2B6—chronic kidney failure	0.0102	0.0102	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.01	0.01	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—SCARB1—chronic kidney failure	0.00989	0.00989	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.00979	0.00979	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.00963	0.00963	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—chronic kidney failure	0.00962	0.00962	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—SCARB1—chronic kidney failure	0.00948	0.00948	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—SCARB1—chronic kidney failure	0.00948	0.00948	CbGpPWpGaD
Tazarotene—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C19—chronic kidney failure	0.00942	0.00942	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.00922	0.00922	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—RETN—chronic kidney failure	0.0089	0.0089	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—chronic kidney failure	0.00863	0.00863	CbGpPWpGaD
Tazarotene—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C19—chronic kidney failure	0.00857	0.00857	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—chronic kidney failure	0.00827	0.00827	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARA—chronic kidney failure	0.00827	0.00827	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.00827	0.00827	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.00793	0.00793	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.00776	0.00776	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—NR3C1—chronic kidney failure	0.00758	0.00758	CbGpPWpGaD
Tazarotene—CYP2C8—CYP2E1 reactions—CYP2C19—chronic kidney failure	0.0073	0.0073	CbGpPWpGaD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—LPL—chronic kidney failure	0.00728	0.00728	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—PPARA—chronic kidney failure	0.0071	0.0071	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.00696	0.00696	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—NR3C1—chronic kidney failure	0.0068	0.0068	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.00667	0.00667	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—LPL—chronic kidney failure	0.00653	0.00653	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—NR3C1—chronic kidney failure	0.00652	0.00652	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—NR3C1—chronic kidney failure	0.00652	0.00652	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—PPARA—chronic kidney failure	0.00637	0.00637	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2B6—chronic kidney failure	0.0063	0.0063	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—LPL—chronic kidney failure	0.00626	0.00626	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—LPL—chronic kidney failure	0.00626	0.00626	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—PPARA—chronic kidney failure	0.00611	0.00611	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—PPARA—chronic kidney failure	0.00611	0.00611	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR3C1—chronic kidney failure	0.00599	0.00599	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARA—chronic kidney failure	0.00561	0.00561	CbGpPWpGaD
Tazarotene—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic kidney failure	0.00555	0.00555	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2C18—chronic kidney failure	0.00546	0.00546	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR3C1—chronic kidney failure	0.00537	0.00537	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—LPIN1—chronic kidney failure	0.00522	0.00522	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR3C1—chronic kidney failure	0.00515	0.00515	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR3C1—chronic kidney failure	0.00515	0.00515	CbGpPWpGaD
Tazarotene—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic kidney failure	0.00505	0.00505	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARA—chronic kidney failure	0.00503	0.00503	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—NR3C1—chronic kidney failure	0.00499	0.00499	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARA—chronic kidney failure	0.00482	0.00482	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARA—chronic kidney failure	0.00482	0.00482	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2C19—chronic kidney failure	0.00452	0.00452	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic kidney failure	0.00452	0.00452	CbGpPWpGaD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP2C19—chronic kidney failure	0.00435	0.00435	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic kidney failure	0.00422	0.00422	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—NAT8—chronic kidney failure	0.00421	0.00421	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic kidney failure	0.00406	0.00406	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic kidney failure	0.00389	0.00389	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic kidney failure	0.00389	0.00389	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—SREBF1—chronic kidney failure	0.0038	0.0038	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic kidney failure	0.00379	0.00379	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic kidney failure	0.00363	0.00363	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic kidney failure	0.00363	0.00363	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP3A4—chronic kidney failure	0.00358	0.00358	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—ADIPOQ—chronic kidney failure	0.00349	0.00349	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CST3—chronic kidney failure	0.00345	0.00345	CbGpPWpGaD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP3A4—chronic kidney failure	0.00344	0.00344	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CST3—chronic kidney failure	0.00331	0.00331	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—TFDP2—chronic kidney failure	0.00299	0.00299	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—TFDP2—chronic kidney failure	0.00268	0.00268	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP1A1—chronic kidney failure	0.00267	0.00267	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2B6—chronic kidney failure	0.00262	0.00262	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—LPL—chronic kidney failure	0.00258	0.00258	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2B6—chronic kidney failure	0.00258	0.00258	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—TFDP2—chronic kidney failure	0.00257	0.00257	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—TFDP2—chronic kidney failure	0.00257	0.00257	CbGpPWpGaD
Tazarotene—CYP2C8—Tamoxifen metabolism—CYP1A1—chronic kidney failure	0.00256	0.00256	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NR3C1—chronic kidney failure	0.00244	0.00244	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARA—chronic kidney failure	0.00228	0.00228	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C18—chronic kidney failure	0.00227	0.00227	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2C18—chronic kidney failure	0.00224	0.00224	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—CYP2C19—chronic kidney failure	0.00217	0.00217	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.00212	0.00212	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—chronic kidney failure	0.00208	0.00208	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—chronic kidney failure	0.00199	0.00199	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS1—chronic kidney failure	0.00199	0.00199	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IRS1—chronic kidney failure	0.00193	0.00193	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.00188	0.00188	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.00185	0.00185	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.00184	0.00184	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IGF1—chronic kidney failure	0.00179	0.00179	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—SERPINE1—chronic kidney failure	0.0017	0.0017	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.00152	0.00152	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—chronic kidney failure	0.00149	0.00149	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—chronic kidney failure	0.00147	0.00147	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—TFDP2—chronic kidney failure	0.00144	0.00144	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.00139	0.00139	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	0.00137	0.00137	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	0.00132	0.00132	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—TFDP2—chronic kidney failure	0.00129	0.00129	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic kidney failure	0.00128	0.00128	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—TFDP2—chronic kidney failure	0.00124	0.00124	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—TFDP2—chronic kidney failure	0.00124	0.00124	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—chronic kidney failure	0.0012	0.0012	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	0.00114	0.00114	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2B6—chronic kidney failure	0.00113	0.00113	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.00111	0.00111	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.00111	0.00111	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.00109	0.00109	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—chronic kidney failure	0.00109	0.00109	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—chronic kidney failure	0.00107	0.00107	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR3C1—chronic kidney failure	0.00103	0.00103	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—chronic kidney failure	0.001	0.001	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	0.000987	0.000987	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2C18—chronic kidney failure	0.000976	0.000976	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARA—chronic kidney failure	0.000969	0.000969	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000963	0.000963	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	0.000947	0.000947	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR3C1—chronic kidney failure	0.000928	0.000928	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.000898	0.000898	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	0.000896	0.000896	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR3C1—chronic kidney failure	0.000889	0.000889	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR3C1—chronic kidney failure	0.000889	0.000889	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARA—chronic kidney failure	0.000869	0.000869	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	0.000859	0.000859	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARA—chronic kidney failure	0.000833	0.000833	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARA—chronic kidney failure	0.000833	0.000833	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.000826	0.000826	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	0.000823	0.000823	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2C19—chronic kidney failure	0.000809	0.000809	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—chronic kidney failure	0.000808	0.000808	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.000798	0.000798	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	0.000789	0.000789	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	0.000768	0.000768	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—chronic kidney failure	0.000762	0.000762	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	0.000762	0.000762	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.000753	0.000753	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—PTGS1—chronic kidney failure	0.00074	0.00074	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	0.000736	0.000736	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	0.00073	0.00073	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—SERPINE1—chronic kidney failure	0.000722	0.000722	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.000669	0.000669	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.000653	0.000653	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—SERPINE1—chronic kidney failure	0.000647	0.000647	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP3A4—chronic kidney failure	0.00064	0.00064	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP3A4—chronic kidney failure	0.000631	0.000631	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SERPINE1—chronic kidney failure	0.000621	0.000621	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SERPINE1—chronic kidney failure	0.000621	0.000621	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	0.000516	0.000516	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	0.000505	0.000505	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR3C1—chronic kidney failure	0.000498	0.000498	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	0.000485	0.000485	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP1A1—chronic kidney failure	0.000477	0.000477	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP1A1—chronic kidney failure	0.00047	0.00047	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARA—chronic kidney failure	0.000467	0.000467	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR3C1—chronic kidney failure	0.000447	0.000447	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	0.000432	0.000432	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	0.000432	0.000432	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR3C1—chronic kidney failure	0.000428	0.000428	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR3C1—chronic kidney failure	0.000428	0.000428	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARA—chronic kidney failure	0.000418	0.000418	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	0.000405	0.000405	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARA—chronic kidney failure	0.000401	0.000401	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARA—chronic kidney failure	0.000401	0.000401	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	0.000391	0.000391	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	0.000383	0.000383	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	0.000375	0.000375	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—POMC—chronic kidney failure	0.000356	0.000356	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SERPINE1—chronic kidney failure	0.000347	0.000347	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FABP1—chronic kidney failure	0.000335	0.000335	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	0.000319	0.000319	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AGXT—chronic kidney failure	0.000318	0.000318	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GATM—chronic kidney failure	0.000318	0.000318	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SERPINE1—chronic kidney failure	0.000312	0.000312	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	0.000311	0.000311	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	0.000311	0.000311	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SERPINE1—chronic kidney failure	0.000299	0.000299	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SERPINE1—chronic kidney failure	0.000299	0.000299	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ACAT1—chronic kidney failure	0.000291	0.000291	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	0.000287	0.000287	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	0.000284	0.000284	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	0.000279	0.000279	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	0.000271	0.000271	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MLXIPL—chronic kidney failure	0.00027	0.00027	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	0.000265	0.000265	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC22A2—chronic kidney failure	0.000247	0.000247	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	0.000242	0.000242	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCG1—chronic kidney failure	0.00023	0.00023	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIP5K1B—chronic kidney failure	0.000225	0.000225	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ARG2—chronic kidney failure	0.00022	0.00022	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LCAT—chronic kidney failure	0.000216	0.000216	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DDC—chronic kidney failure	0.000198	0.000198	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2B6—chronic kidney failure	0.000193	0.000193	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PRKAG2—chronic kidney failure	0.000193	0.000193	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PRKD1—chronic kidney failure	0.000193	0.000193	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	0.00019	0.00019	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	0.000183	0.000183	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SREBF2—chronic kidney failure	0.00018	0.00018	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCKR—chronic kidney failure	0.000174	0.000174	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCC3—chronic kidney failure	0.000174	0.000174	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPIN1—chronic kidney failure	0.00017	0.00017	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	0.000167	0.000167	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2C18—chronic kidney failure	0.000167	0.000167	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LRP2—chronic kidney failure	0.000167	0.000167	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CPT1A—chronic kidney failure	0.000142	0.000142	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LIPC—chronic kidney failure	0.000138	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2C19—chronic kidney failure	0.000138	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	0.000137	0.000137	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SCARB1—chronic kidney failure	0.000128	0.000128	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS1—chronic kidney failure	0.000127	0.000127	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	0.000124	0.000124	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SREBF1—chronic kidney failure	0.000124	0.000124	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMGCR—chronic kidney failure	0.000121	0.000121	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FASN—chronic kidney failure	0.000118	0.000118	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	0.000109	0.000109	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	0.000109	0.000109	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCA1—chronic kidney failure	0.000108	0.000108	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAT—chronic kidney failure	9.11e-05	9.11e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCB1—chronic kidney failure	8.86e-05	8.86e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPL—chronic kidney failure	8.44e-05	8.44e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	8.15e-05	8.15e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTHFR—chronic kidney failure	7.6e-05	7.6e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARA—chronic kidney failure	7.46e-05	7.46e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—POMC—chronic kidney failure	6.08e-05	6.08e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—chronic kidney failure	5.54e-05	5.54e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NOS3—chronic kidney failure	5.3e-05	5.3e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—chronic kidney failure	4.85e-05	4.85e-05	CbGpPWpGaD
